Huajin Capital
Overview
Zhuhai Huajin Capital Co., Ltd. is a key player in the financial investment sector, specializing in diversified industrial investment and asset management. The company's primary function is to support economic development through strategic investments in various sectors, thereby enhancing its portfolio's value. It engages in venture capital, private equity, and other financial services, aiming to generate sustainable returns while supporting emerging technologies and growing industries. The company has a strong presence in manufacturing sectors, playing a pivotal role in the semiconductor and information technology industries. It is also involved in real estate development, operation and management of digital information industry parks, public facilities management, infrastructure construction, and other activities.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Arnatar Therapeutics | Dec 2024 | Series A | Co-investor |
| Bivision Pharma | Jul 2024 | Series A | Lead |
| Arnatar Therapeutics | Apr 2024 | Series A | Co-investor |
| Innovo Therapeutics | Dec 2023 | Early Funding | Lead |
| 成都赜灵生物医药科技有限公司 | Nov 2023 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.